Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT01234818
Eligibility Criteria:
Inclusion Criteria:
1. Patients who are histological confirmed as endometrial hyperplasia
2. Patients who don't want hysterectomy
3. Patients signed the written informed consent voluntarily
Exclusion Criteria:
1. Pregnancy or suspicion of pregnancy
2. Under treatment of metastatic cancer from other organs or less than 5 years after previous cancer therapy
3. Congenital or acquired uterine anomaly including fibroids if they distort the uterine cavity
4. Genital (vaginal, uterine or ovarian) infection
5. Acute liver disease or liver tumor (benign or malignant)
6. Thrombosis or phlebothrombosis requiring treatment
7. Acute severe disease of arteries such as stroke or heart infarction or a history of artery disease
8. Hypersensitivity to any component of this product
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Study:
NCT01234818
Study Brief:
Protocol Section:
NCT01234818